The First "Age Reversal" Human Trial Is Here: How it works and Why it probably won't benefit you скачать в хорошем качестве

The First "Age Reversal" Human Trial Is Here: How it works and Why it probably won't benefit you

The first human clinical trial has officially begun for Epigenetic Reprogramming—a medical miracle that doesn't just slow aging, but reverses it. This episode walks you through how it works, the impact it will have on our society, and why it might lead to a very dark future for most people alive today. ______________________________________________________________________ Self-promotion: I built my own AI-powered document research tool to analyze the papers and materials used to make this video. It’s a privacy-first, fact-grounded app that runs entirely on your desktop. You can chat with your documents for quick answers or use the deep Research Mode to distill expert-level insights into comprehensive reports—all backed by verifiable references. Unlike conventional RAG tools or chatbots like ChatGPT, it uses a highly efficient agentic workflow to ensure outputs are significantly more accurate and reliable. Start your 2-week free trial today: https://cognitodoc.com/ Demo:    • CognitoDoc: Your Private AI-Powered Docume...   Programmable Access Demo (Use In Slack):    • CognitoDoc Programmable Access Demo: Use i...   ______________________________________________________________________ References: https://www.lifebiosciences.com/news/... The epigenetic rejuvenation promise: Partial reprogramming as a therapeutic strategy for aging and disease (2026) https://doi.org/10.1016/j.arr.2026.10... Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2024) https://doi.org/10.1038/s43587-023-00... Transplantation of derivative retinal organoids from chemically induced pluripotent stem cells restored visual function (2024) https://doi.org/10.1038/s41536-024-00... Genetic engineering and the eye (2024) https://doi.org/10.1038/s41433-024-03... Epigenetic reprogramming as a key to reverse ageing and increase longevity (2024) https://doi.org/10.1016/j.arr.2024.10... Sustained Vision Recovery by OSK Gene Therapy in a Mouse Model of Glaucoma (2023) https://doi.org/10.1089/cell.2023.0074 Reprogramming to recover youthful epigenetic information and restore vision (2020) https://doi.org/10.1038/s41586-020-29...